Adiponectin as a biomarker for metabolic syndrome among patients on atypical antipsychotics

被引：0
|
作者：
Bai, Y. M. [1 ]
Chen, J. Y. [2 ]
Lin, C. C. [3 ]
Shiung, Y. W. [3 ]
Chen, T. T. [2 ]
Su, T. P. [1 ]
机构：
[1] Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan
[2] Yu Li Vet Hosp, Dept Psychiat, Hualien, Taiwan
[3] Natl Taiwan Univ Hosp, Dept Psychiat, Taipei, Taiwan
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2008年 / 18卷
关键词：
D O I：
10.1016/S0924-977X(08)70617-5
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S422 / S423
页数：2
相关论文
共 50 条
  • [31] PREVALENCE OF THE METABOLIC SYNDROME AMONG SCHIZOPHRENIA PATIENTS ON ANTIPSYCHOTICS IN NIGERIA
    James, Bawo O.
    Lawani, Ambrose A.
    Okolo, Modupe
    Morakinyo, Olufemi
    SCHIZOPHRENIA RESEARCH, 2010, 117 (2-3) : 505 - 505
  • [32] Differential effects of atypical antipsychotics on indices of metabolic syndrome
    Meyer, J
    Newcomer, JW
    Loebel, AD
    Cohen, GM
    SCHIZOPHRENIA BULLETIN, 2005, 31 (02) : 566 - 566
  • [33] Differential effects of atypical antipsychotics on indices of metabolic syndrome
    Newcomer, JW
    Meyer, J
    Loebel, A
    Cohen, GM
    NEUROPSYCHOPHARMACOLOGY, 2004, 29 : S219 - S220
  • [34] Biological perspectives - Metabolic syndrome: Schizophrenia and atypical antipsychotics
    Keltner, Norman L.
    PERSPECTIVES IN PSYCHIATRIC CARE, 2006, 42 (03) : 204 - 207
  • [35] Metabolic syndrome and atypical antipsychotics: Possibility of prediction and control
    Franch Pato, Clara M.
    Molina Rodriguez, Vicente
    Franch Valverde, Juan I.
    REVISTA DE PSIQUIATRIA Y SALUD MENTAL, 2017, 10 (01): : 38 - 44
  • [36] Adiponectin/resistin evaluation is a gold biomarker for monitoring CVD in patients with metabolic syndrome
    Abdelmonem, M.
    Alawssi, Y.
    Ahmed, K.
    Alqaisi, K.
    Wasim, H.
    Abdelmageed, M.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2023, 160 : S16 - S16
  • [37] Adiponectin/resistin evaluation is a gold biomarker for monitoring CVD in patients with metabolic syndrome
    Abdelmonem, M.
    Alawssi, Y.
    Ahmed, K.
    Alqaisi, K.
    Wasim, H.
    Abdelmageed, M.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2023, 160 : S16 - S16
  • [38] Adiponectin as a potential biomarker for the metabolic syndrome in Chinese patients taking clozapine for schizophrenia
    Bai, Ya Mei
    Chen, Jen-Yeu
    Yang, Wei-Shiung
    Chi, Yu-Chiao
    Liou, Ying-Jay
    Lin, Chao-Cheng
    Wang, Ying-Chieh
    Lin, Chih-Yuan
    Su, Tung-Pine
    Chou, Pesus
    JOURNAL OF CLINICAL PSYCHIATRY, 2007, 68 (12) : 1834 - 1839
  • [39] Atypical Antipsychotics and Metabolic Syndrome in Patients with Schizophrenia: Risk Factors, Monitoring, and Healthcare Implications
    Riordan, Henry J.
    Antonini, Paola
    Murphy, Michael F.
    AMERICAN HEALTH AND DRUG BENEFITS, 2011, 4 (05): : 292 - 301
  • [40] Cytokine Level Changes in Schizophrenia Patients with and without Metabolic Syndrome Treated with Atypical Antipsychotics
    Boiko, Anastasiia S.
    Mednova, Irina A.
    Kornetova, Elena G.
    Gerasimova, Valeria I.
    Kornetov, Alexander N.
    Loonen, Anton J. M.
    Bokhan, Nikolay A.
    Ivanova, Svetlana A.
    PHARMACEUTICALS, 2021, 14 (05)
12345